Company Overview of Meditope Biosciences, Inc.
Meditope Biosciences, Inc., a biotechnology company, develops antibody based cancer therapeutics. The company was founded in 2011 and is based in Pasadena, California.
301 North Lake Avenue
Pasadena, CA 91101
Founded in 2011
Key Executives for Meditope Biosciences, Inc.
Chief Executive Officer and President
Executive Vice President of Business Development and Director
Vice President of Translational Research
Compensation as of Fiscal Year 2015.
Meditope Biosciences, Inc. Key Developments
Meditope Biosciences Announces New Executive and Board Appointments
Jan 6 15
Meditope Biosciences, Inc. announced two new leadership appointments: Robert Kramer, Ph.D., has joined the company's board of directors and Bob McKenzie, a current board member, has joined as Executive Vice President of Business Development. Dr. Kramer is an established pharmaceutical research executive with over 23 years of oncology drug discovery and development experience. Most recently, he was Global Head of Oncology Drug Discovery at Janssen (a Johnson & Johnson company). Bob McKenzie brings more than 25 years of experience in worldwide business development, as well as general and operational management expertise in sales and marketing, primarily in the technology industry. He was most recently vice president at Amdocs, a global leader in outsourced business services, where he oversaw key global accounts in the company's Broadband, Cable and Satellite division, and was responsible for strategic planning in the cable and satellite industry, product development, business development and program delivery.
Meditope Biosciences, Inc. Presents at 13th Annual BIO Investor Forum, Oct-07-2014 01:30 PM
Sep 9 14
Meditope Biosciences, Inc. Presents at 13th Annual BIO Investor Forum, Oct-07-2014 01:30 PM. Venue: The Palace Hotel, San Francisco, CA 94105, United States.
Meditope Biosciences, Inc. Appoints C. Dan Dumitru as Vice President of Translational Research
May 19 14
Meditope Biosciences, Inc. announced the appointment of C. Dan Dumitru, M.D., Ph.D., as Vice President of Translational Research. Dr. Dumitru is currently a member of the Department of Chemical Physiology at the Scripps Research Institute in San Diego. He was previously director of physiology at aTyr Pharma, where he oversaw preclinical and early clinical drug development programs for inflammatory and neurodegenerative diseases.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|